1. Home
  2. ESSA vs ELDN Comparison

ESSA vs ELDN Comparison

Compare ESSA & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESSA
  • ELDN
  • Stock Information
  • Founded
  • ESSA 1916
  • ELDN 2004
  • Country
  • ESSA United States
  • ELDN United States
  • Employees
  • ESSA N/A
  • ELDN N/A
  • Industry
  • ESSA Banks
  • ELDN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ESSA Finance
  • ELDN Health Care
  • Exchange
  • ESSA Nasdaq
  • ELDN Nasdaq
  • Market Cap
  • ESSA 184.4M
  • ELDN 178.4M
  • IPO Year
  • ESSA N/A
  • ELDN N/A
  • Fundamental
  • Price
  • ESSA $20.57
  • ELDN $3.41
  • Analyst Decision
  • ESSA
  • ELDN Strong Buy
  • Analyst Count
  • ESSA 0
  • ELDN 2
  • Target Price
  • ESSA N/A
  • ELDN $12.50
  • AVG Volume (30 Days)
  • ESSA 44.9K
  • ELDN 683.3K
  • Earning Date
  • ESSA 07-23-2025
  • ELDN 08-18-2025
  • Dividend Yield
  • ESSA 2.93%
  • ELDN N/A
  • EPS Growth
  • ESSA N/A
  • ELDN N/A
  • EPS
  • ESSA 1.55
  • ELDN N/A
  • Revenue
  • ESSA $66,345,000.00
  • ELDN N/A
  • Revenue This Year
  • ESSA $9.38
  • ELDN N/A
  • Revenue Next Year
  • ESSA N/A
  • ELDN N/A
  • P/E Ratio
  • ESSA $13.24
  • ELDN N/A
  • Revenue Growth
  • ESSA N/A
  • ELDN N/A
  • 52 Week Low
  • ESSA $15.82
  • ELDN $2.38
  • 52 Week High
  • ESSA $22.22
  • ELDN $5.54
  • Technical
  • Relative Strength Index (RSI)
  • ESSA 68.42
  • ELDN 72.59
  • Support Level
  • ESSA $18.62
  • ELDN $3.00
  • Resistance Level
  • ESSA $20.89
  • ELDN $3.16
  • Average True Range (ATR)
  • ESSA 0.44
  • ELDN 0.18
  • MACD
  • ESSA 0.19
  • ELDN 0.09
  • Stochastic Oscillator
  • ESSA 86.51
  • ELDN 99.46

About ESSA ESSA Bancorp Inc.

ESSA Bancorp Inc is a holding company, engaged in accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in residential first mortgage loans (including construction mortgage loans), commercial real estate loans, home equity loans and lines of credit and commercial and industrial loans. The company offers a variety of deposit accounts, including checking, savings and certificates of deposit. The company also offers asset management and trust services and investment services. The company also offers insurance benefit consulting services through its wholly-owned subsidiary, ESSA Advisory Services, LLC.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: